Sands Capital Ventures’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Sands Capital Ventures’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-778,922	Closed	-$48.4M	–	21
2023 Q4	$48.4M	Sell	778,922 -416,667	-35%	-$10.4M	13.47%	4
2023 Q3	$26.5M	Buy	+1,195,589	New	+$25.1M	7.85%	5

Sands Capital Ventures's RYZB Position: Q1 2024 in Review

Sands Capital Ventures sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 778,922 shares — an estimated $48.4M sold.

Sands Capital Ventures first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $48.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Sands Capital Ventures reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Sands Capital Ventures sold 778,922 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $48.4M.
Sands Capital Ventures first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Sands Capital Ventures's RayzeBio, Inc. Common Stock position peaked at $48.4M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Sands Capital Ventures's 13F filing for Q1 2024, filed 14 May 2024.